Reduction of RPT6/S8 (a Proteasome component) and proteasome activity in the cortex is associated with cognitive impairment in Lewy body dementia
Manuscript Number:
16-0946R2
Author(s):
Dag Aarsland, Amani Alghamdi, Johannes Attems, Clive G. Ballard, Martin Broadstock, Paul T. Francis, Tibor Hortobágyi, David Howlett, John T. O’Brien, Alan J. Thomas, Julie Vallortigara, David Whitfield
Disclosures
Dag Aarsland
Consulting Fees:
Dr Aarsland has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and serves as paid consultant for H. Lundbeck, Eisai, and Axovant.
Dag Aarsland is a Royal Society Wolfson Research Merit Award Holder and would like to thank the Wolfson Foundation and the Royal Society for their support
Lecture Fees:
Dr Aarsland has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and serves as paid consultant for H. Lundbeck, Eisai, and Axovant.
Amani Alghamdi
Nothing to Disclose
Johannes Attems
Nothing to Disclose
Clive G. Ballard
Consulting Fees:
personal fees from Roche, Orion, GlaxoSmithKline, Otusaka, Heptares and Lilly. D.A. has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, paid consultant for H. Lundbeck and Axovant